Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: VTAK )

0.5489 -0.0111 (-1.98%)
Official Closing Price Updated: 6:30 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,489
Open 0.5500
Bid (Size) 0.5300 (4)
Ask (Size) 0.5900 (1)
Prev. Close 0.5600
Today's Range 0.5175 - 0.5800
52wk Range 0.3400 - 0.7480
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Stock Surges Following LockeT Purchase Order from HCA Healthcare
Via AB Newswire

Performance

YTD
+36.03%
+36.03%
1 Month
+10.18%
+10.18%
3 Month
-4.21%
-4.21%
6 Month
+31.03%
+31.03%
1 Year
+0.92%
+0.92%

More News

Read More
Stocks Creating Buzz Look Now: VTAK, AMST, HOOK, MULN, KAVL
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility
Via ACCESSWIRE
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
Medical Device Innovator Catheter Precision Inc. (NYSE American: VTAK) Gains Momentum with LockeT and VIVO™ Products – Full Analysis Inside!
Via AB Newswire
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
Via AB Newswire
Catheter Precision (NYSE American: VTAK) Shows Fiscal Strength, Solid Growth and Strategic Moves; Bullish Momentum Seen in Stock Price
Via AB Newswire
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023
Via ACCESSWIRE
March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
Via AB Newswire
Topics Energy
Exposures Fossil Fuels
Catheter Precision Inc. (NYSE American: VTAK) Surges with VIVO™ Success
Via AB Newswire
Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar
Via ACCESSWIRE
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
Market Spotlight: Catheter Precision Inc (NYSE American: VTAK) Emerges as a Key Stock to Watch
Via AB Newswire
Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States
Via ACCESSWIRE
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
Exposures Product Safety
Medical Innovations Spotlight: Catheter Precision’s VIVO™ Revolutionizes Cardiac Procedures
Via AB Newswire
Exposures Product Safety
Catheter Precision Inc (NYSE American: VTAK) Marks Milestone: VIVO Used Successfully with Pediatric Patient
Via AB Newswire
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.